Project Grant HT9425261E223
Award Date 9/30/26
Completion Date 9/29/29
Dollars Obligated $416K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of the City of Hope a $1.4 million Project Grant on August 31, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research targeting aberrant end-joining repair for improving treatment of mixed phenotype acute leukemia. The three-year project, which extends through July 31, 2029, will be conducted at the Institute's research facility in Irwindale, California....
- Federal Project Grant Award Summary Funding Organization & Program: The Defense Health Agency (DHA) awarded $2,083,719 under the Military Medical Research and Development program (CFDA 12.420) to support biomedical research addressing Service Member health priorities. Project Scope & Deliverables: California Institute of Technology (Caltech) will develop and validate photoacoustic computed tomography (PACT) technology to identify and diagnose axillary lymph nodes in breast cancer...
- Federal Grant Award Summary Beckman Research Institute of the City of Hope received a $2.136 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2028. The award supports developmental therapeutics research and the investigation of potential treatment strategies targeting RALBP1 (Retinoid-binding Protein 1) for castration-resistant prostate carcinoma. This...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded $177,992 to Beckman Research Institute of The City of Hope under the Military Medical Research and Development program (CFDA 12.420) for the project "Generation of Novel Tools for the Development of Targeted Approaches for AL Amyloidosis." The two-year award period runs from September 1, 2025, through August 31, 2027, with research conducted at the Institute's Irwindale, California facility. This project supports DHA's...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $140,000 under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope, effective September 1, 2026 through August 31, 2027. This one-year project grant funds research on "Enhancing TIL Trafficking via Paired Cell Engineering and Lipid Nanoparticle Modulation of the Tumor Microenvironment in Mucosal Melanoma," with research activities conducted...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. received a $1.12M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2026, through August 31, 2030. The award supports resource development activities aimed at improving clinical and research outcomes for blastic plasmacytoid dendritic cell neoplasm, a rare hematologic malignancy. The project deliverables will advance knowledge and...
- Federal Project Grant Award Summary Baylor College of Medicine received a $500,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2029. The award funds research to develop rat models of lobular carcinoma of the breast, a specialized research initiative supporting the DHA's mission to advance biomedical solutions for Service Member health and the military population. This...
- Federal Project Grant Award Summary The Beckman Research Institute of the City of Hope received a $1.32M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 15, 2025, with completion targeted for September 14, 2029. The award supports research titled "Targeting Diabetes-Associated Radioresistance to Improve Prostate Cancer Control and Quality-of-Life Outcomes," conducted at the...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $1.1M to the Beckman Research Institute of the City of Hope under the Military Medical Research and Development program (CFDA 12.420) to develop LRRC15-targeted Chimeric Antigen Receptor (CAR) T cell therapy for osteosarcoma. The three-year project, initiated June 1, 2026 and concluding May 31, 2029, will be conducted at the Institute's Irwindale, California research facility. This award represents DHA's commitment to...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded MD Anderson Cancer Center a $560K Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2028. The award supports research on modulating hypoxia-activated stromal programs to potentiate chimeric antigen receptor T (CAR-T) cell therapy in kidney cancer. This project directly aligns with the DHA's mission to advance biomedical solutions for Service...